Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 10	$ 8
Accounts receivable - trade (less allowance for doubtful accounts)	600	434
Unbilled revenue	446	301
Miscellaneous accounts receivable	54	85
Inventories	667	592
Current regulatory assets	354	319
Investments in Industrial Development Revenue Bonds	240
Current collateral assets	142	66
Other current assets	155	155
Total current assets	2,668	1,968
Property, Plant, and Equipment, Net	31,262	29,261
Investments and Other Assets:
Nuclear decommissioning trust fund	958	1,159
Goodwill	411	411
Regulatory assets	1,426	1,289
Pension and other postretirement benefits	411	756
Other assets	768	891
Total investments and other assets	3,974	4,506
TOTAL ASSETS	37,904	35,735
Current Liabilities:
Current maturities of long-term debt	340	505
Short-term debt	1,070	545
Accounts and wages payable	1,159	1,095
Other current liabilities	797	681
Total current liabilities	3,366	2,826
Long-term Debt, Net	13,685	12,562
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and investment tax credits, net	3,804	3,499
Regulatory liabilities	5,309	5,848
Asset retirement obligations	763	757
Other deferred credits and liabilities	340	414
Total deferred credits and other liabilities	10,216	10,518
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders' Equity:
Common stock	3	3
Other paid-in capital, principally premium on common stock	6,860	6,502
Retained earnings	3,646	3,182
Accumulated other comprehensive income (loss)	(1)	13
Total shareholders' equity	10,508	9,700
Noncontrolling Interests	129	129
Total equity	10,637	9,829
TOTAL LIABILITIES AND EQUITY	$ 37,904	$ 35,735